Synthesis of peptide–siRNA conjugates via internal sulfonylphosphoramidate modifications and evaluation of their in vitro activity

• Published in: Nucleic acids research 2024-01, Vol.52 (1), p.49-58
• Main Authors: Smidt, Jakob Melgaard, Lykke, Lennart, Stidsen, Carsten Enggaard, Pristovšek, Nuša, Gothelf, Kurt V
• Format: Article
• Language: English
• Subjects: Chemical Biology and Nucleic Acid Chemistry
• ISSN: 0305-1048; 1362-4962
• DOI: 10.1093/nar/gkad1015

Abstract Conjugates of therapeutic oligonucleotides (ONs) including peptide conjugates, provide a potential solution to the major challenge of specific tissue delivery faced by this class of drugs. Conjugations are often positioned terminal at the ONs, although internal placement of other chemical modifications are known to be of critical importance. The introduction of internal conjugation handles in chemically modified ONs require highly specialized and expensive nucleoside phosphoramidites. Here, we present a method for synthesizing a library of peptide–siRNA conjugates by conjugation at internal phosphorous positions via sulfonylphosphoramidate modifications incorporated into the sense strand. The sulfonylphosphoramidate modification offers benefits as it can be directly incorporated into chemically modified ONs by simply changing the oxidation step during synthesis, and furthermore holds the potential to create multifunctionalized therapeutic ONs. We have developed a workflow using a novel pH-controlled amine-to-amine linker that yields peptide–siRNA conjugates linked via amide bonds, and we have synthesized conjugates between GLP1 peptides and a HPRT1 siRNA as a model system. The in vitro activity of the conjugates was tested by GLP1R activity and knockdown of the HPRT1 gene. We found that conjugation near the 3′-end is more favorable than certain central internal positions and different internal conjugation strategies were compared. Graphical Abstract Graphical Abstract